Sort   by:  
 Page size 
UnknownThe Clinical Outcome Study for dysferlinopathy: An international multicenter study.
Not available
S-EPMC4994875 | biostudies-literature
UnknownClinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings.
Not available
S-EPMC3357954 | biostudies-literature
UnknownSocial deprivation in Duchenne muscular dystrophy: population based study.
Not available
S-EPMC59456 | biostudies-literature
UnknownChallenges raised by cross-border testing of rare diseases in the European union.
Not available
S-EPMC5110067 | biostudies-literature
UnknownPrevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.
Not available
S-EPMC4038491 | biostudies-literature
UnknownMutations in INPP5K, Encoding a Phosphoinositide 5-Phosphatase, Cause Congenital Muscular Dystrophy with Cataracts and Mild Cognitive Impairment.
Not available
S-EPMC5339217 | biostudies-literature
UnknownThe burden of Duchenne muscular dystrophy: an international, cross-sectional study.
Not available
S-EPMC4141999 | biostudies-literature
UnknownMuscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.
Not available
S-EPMC4746763 | biostudies-literature
UnknownCalpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.
Not available
S-EPMC2900895 | biostudies-literature
UnknownPhenotypic variability of TRPV4 related neuropathies.
Not available
S-EPMC4454778 | biostudies-literature
Sort   by:  
 Page size